Meredith Gonnason is an experienced creative professional and is currently the Senior Director of Multichannel Production at Synchrony Healthcare Communications. Since finishing her undergrad at Princeton University she has called many places home including Thailand, Los Angeles and Las Vegas. She currently lives in the Philadelphia area with her husband James and twin toddlers, Chloe […]
At this event, you will learn how the team at the MassGeneral Institute for Neurodegenerative Disease is working to identify new therapeutic targets for ALS.
https://iamals.org/action/physicians-perceptions-of-people-with-disability-and-their-health-care/ Having a disability shouldn’t lead to receiving substandard care, symptoms and primary health care concerns overlooked or pain or discomfort ignored. Unfortunately this happens all too often and isn’t talked about enough. I AM ALS is pleased to host ALS advocate Michael Robinson, MD and Lisa Iezzoni, MD, MSc in a conversation that brings […]
Join us for a HEALEY ALS Platform Trial Q&A Our investigators and study team will be available to answer any and all questions that the you might have about the trial. https://t.co/M1rpdzRw05
Join us for a HEALEY ALS Platform Trial Q&A Our investigators and study team will be available to answer any and all questions that the you might have about the trial. https://t.co/M1rpdzRw05
Join us via zoom for an in depth scientific on why the brain matters in ALS. Moderated by: Doug McConnell, A Long Swim Co-Founder Hosted by: Dr. Hande Ozdinler, Scientific Director and Associate Professor of Neurology at Northwestern University Feinberg School, and Andrew Eisen MD., FRCPC, Professor Emeritus of Neurology at the University of British […]
From Center for Medicare Advocacy - Practical points as well as advocacy topics.
Neuroinflammation is a major driving force in the pathophysiology of the neurodegenerative diseases ALS and Alzheimer Disease. Such neuroinflammation is characterized by alterations of the immune system - primarily the presence of pro-inflammatory macrophages and microglia, as well as dysfunctional regulatory T-lymphocytes (known as Tregs). Together these promote neuronal degeneration and contribute significantly to the […]
Featuring Melinda Kavanaugh, PhD, MSW, LCSW, Associate Professor, Social Work and Director in Social Welfare at the Helen Bader School of Social Welfare at the University of Wisconsin-Milwaukee Despite the growing focus on people living with ALS and their adult caregivers, children and youth caregivers, or “young caregivers,” remain the most hidden […]
Join us for a HEALEY ALS Platform Trial Q&A Our investigators and study team will be available to answer any and all questions that the you might have about the trial. https://t.co/M1rpdzRw05
Announcing a new NEALS webinar series on ALS drug development moderated by Dr. Richard Bedlack from the Duke ALS Clinic. This series will include talks on the preclinical development of potential therapies, the regulatory pathway, the science of trials, the clinical trial site level overview, and the importance of patient engagement. In this installment of […]